Stock listing

TPEx:4197 Visgeneer, Inc. (暐世) 股價

Follow Visgeneer, Inc. into a list and get an email when it puts out news.

Share price · TPEX:4197

$7.15 TWD -0.15 (-2.1%)

Close on Nov 20, 2026

Past year -29.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$7.06 – $7.20 TWDNov 20, 2026
Volume
46,000 sharesNov 20, 2026
Market cap
$215.8M TWDAt the close on Nov 20, 2026 · price × 30.18M shares outstanding
52-week range
$7.06 – $22.50 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$773,788 TWDMedian day 16,606 shares · 4 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Visgeneer, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:4197 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$7.15-0.15-2.1%$7.08$7.20$7.0646,000
$7.30-0.14-1.9%$7.42$7.47$7.2058,151
$7.44-0.34-4.4%$7.44$7.44$7.440
$7.78+0.38+5.1%$7.45$7.78$7.4126,001
$7.40-0.37-4.8%$7.41$7.43$7.4018,500
$7.77-0.03-0.4%$7.41$7.78$7.4126,201
$7.800.000.0%$7.80$7.80$7.801
$7.80+0.15+2.0%$7.53$7.80$7.459,001
$7.65-0.13-1.7%$7.42$7.65$7.423,350
$7.78+0.43+5.9%$7.44$7.78$7.4034,300
$7.35-0.68-8.5%$7.80$7.88$7.3094,800
$8.03+0.10+1.3%$7.71$8.03$7.7046,200
$7.93-0.27-3.3%$7.90$7.94$7.6038,600
$8.20-0.11-1.3%$7.92$8.20$7.9139,410
$8.310.000.0%$8.31$8.31$8.310
$8.310.000.0%$7.91$8.31$7.912,000
$8.31-0.14-1.7%$8.27$8.32$7.9234,562
$8.45+0.13+1.6%$8.27$8.54$8.275,050
$8.32+0.02+0.2%$8.01$8.32$8.0010,000
$8.300.000.0%$8.30$8.30$8.300
$8.30-0.35-4.0%$8.27$8.30$8.2613,380
$8.65+0.30+3.6%$8.65$8.65$8.6510
$8.35+0.08+1.0%$8.70$8.70$8.274,700
$8.27-0.42-4.8%$8.27$8.27$8.270
$8.69+0.29+3.5%$8.69$8.69$8.272,233
$8.400.000.0%$8.31$8.40$8.306,220
$8.40-0.10-1.2%$8.42$8.72$8.31211,692
$8.50-0.25-2.9%$8.42$8.84$8.4212,731
$8.75-0.09-1.0%$8.70$8.78$8.7020,001
$8.84+0.19+2.2%$8.65$9.10$8.6539,586
$8.65-0.40-4.4%$9.05$9.05$8.6059,634
$9.05-0.07-0.8%$8.70$9.18$8.36155,709
$9.12+0.12+1.3%$9.10$9.14$8.707,103
$9.00-0.09-1.0%$8.69$9.09$8.6634,603
$9.09+0.19+2.1%$9.00$9.09$8.6911,202
$8.90-0.23-2.5%$9.14$9.14$8.68130,507
$9.130.000.0%$9.13$9.13$8.7141,163
$9.130.000.0%$9.13$9.13$8.7114,105
$9.13-0.13-1.4%$9.31$9.31$8.55103,321
$9.26-0.05-0.5%$9.31$9.31$8.8728,006
$9.31-0.01-0.1%$9.32$9.32$8.8755,506
$9.32+0.03+0.3%$9.30$9.33$8.89101,613
$9.29+0.05+0.5%$9.25$9.33$8.8716,606
$9.24+0.05+0.5%$9.20$9.30$8.8583,113
$9.19-0.55-5.6%$9.73$9.73$8.86112,669
$9.74-0.81-7.7%$10.55$10.55$9.27165,254
$10.55-1.65-13.5%$11.70$11.80$9.96405,724
$12.20-0.50-3.9%$12.90$14.70$10.95869,596
$12.70+2.88+29.3%$9.99$12.95$9.931,138,506
$9.82+0.90+10.1%$9.20$9.82$9.00208,209
$8.92+0.35+4.1%$8.94$9.36$8.9236,103
$8.570.000.0%$8.57$8.57$8.572,000
$8.570.000.0%$8.17$8.57$8.176,000
$8.570.000.0%$8.57$8.57$8.571,000
$8.570.000.0%$8.57$8.57$8.571
$8.57+0.38+4.6%$8.57$8.57$8.5748
$8.190.000.0%$8.19$8.19$8.196,000
$8.19-0.38-4.4%$8.19$8.19$8.191,000
$8.570.000.0%$8.17$8.57$8.1751
$8.57+0.41+5.0%$8.16$8.57$8.1610,001
$8.16-0.05-0.6%$8.57$8.57$8.165
$8.21+0.05+0.6%$8.57$8.57$8.169,045
$8.16-0.41-4.8%$8.16$8.16$8.162,000

Splits

3 splits since 2014 · TPEX:4197 · every price before a split is adjusted for it

DayRatioWhat
21-for-20Split
21-for-20Split
11-for-10Split
Ticker
TPEx:4197
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
TPEx
Currency
TWD

Visgeneer, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services

Valuation

P/E 41.1× against a median of 3.7×: the highest of 3 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$263.4M TWD
P/E
41.1×
EV/sales
1.5×
EV/EBITDA
36.6×
Price/book
1.1×
Gross margin
38.2%
Operating margin
−3.0%
Net margin
2.9%
Debt to equity
0.5×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Visgeneer, Inc. · TPEX:4197US$6.55MUS$7.99M41.1×1.5×36.6×1.1×2.9%0.5×n/a
Atomo Diagnostics Ltd. · ASX:AT1US$7.77MUS$5.56Mn/a1.6×n/a1.5×−65.9%0.1×n/a
Fusion Antibodies PLC · LSE:FABUS$6.96MUS$6.03Mn/a2.2×n/a3.3×−54.4%0.2×n/a
IDL Diagnostics AB · OMXSTO:IDLDXUS$6.83MUS$4.56M4.6×0.8×n/a0.5×25.8%0.1×n/a
Milton Essex S.A. · NEWCONNECT:MTNUS$6.07MUS$6.06Mn/a17,573×n/a0.5×n/a0.0×n/a
iXensor Co., Ltd. · TPEX:6734US$6.01MUS$5.63Mn/a6.9×n/a23.1×−174.7%0.9×n/a
Cizzle Biotechnology Holdings PLC · LSE:CIZUS$5.70MUS$5.59Mn/an/an/an/an/an/an/a
AcouSort AB · OMXSTO:ACOUUS$5.69MUS$4.76Mn/a6.1×n/a5.9×−140.8%0.0×n/a
GENinCode PLC · LSE:GENIUS$5.42MUS$2.86Mn/a0.7×n/a2.0×−185.5%0.1×n/a
Nanologica AB · OMXSTO:NICAUS$5.29MUS$8.67M2.9×1.6×n/a0.3×34.9%0.3×n/a
VivoSim Labs, Inc. · NASDAQ:VIVSUS$5.29M−US$2.76Mn/a−20.5×n/a0.7×n/a0.1×1.91
Median of the othersUS$5.85MUS$5.57M3.7×1.6×1.5×−65.9%0.1×1.91

Team and board

Officers

OfficerRole
Ken-Shwo DaiChairman & CEO

Board

DirectorRole
Ken-Shwo DaiChairman & CEO

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue179.1M115.8M148.0M158.0M165.3M176.0M152.0M142.5M157.6M163.0M
Cost of revenue110.7M62.5M80.5M90.6M98.0M113.7M114.6M104.2M118.3M94.2M
Gross profit68.4M53.3M67.5M67.3M67.3M62.2M37.4M38.3M39.3M68.8M
Research and development25.0M25.7M25.4M25.4M26.1M23.1M24.3M27.8M26.9M21.7M
Selling, general and administrative48.8M48.0M28.6M26.4M27.1M27.3M28.9M43.9M36.4M44.5M
Operating income-5.41M-20.5M3.99M15.2M3.60M256.0K-30.3M-33.5M-24.0M2.59M
Depreciation and amortization12.6M13.7M17.2M19.2M15.6M20.4M20.7M20.6M20.5M20.7M
EBITDA7.19M-6.80M21.2M34.4M19.2M20.7M-9.60M-12.9M-3.48M23.3M
Interest expense2.43M3.25M3.38M2.90M2.30M2.89M2.80M2.98M00
Income before tax5.25M-17.7M-19.6M12.3M1.33M-2.43M-31.8M-32.6M-33.0M542.0K
Income tax508.0K-3.03M-690.0K-2.35M161.0K
Net income5.25M-17.7M-19.6M12.3M820.0K603.0K-31.8M-31.9M-30.7M381.0K
Earnings per share, basic0.17-0.59-0.650.410.030.02-1.05-1.06-1.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents69.3M70.4M127.3M185.3M88.1M74.4M147.6M110.8M180.3M149.8M
Short-term investments5.80M45.7M5.80M5.80M
Receivables22.9M15.1M14.3M47.2M45.9M98.0M43.7M26.8M53.9M20.9M
Inventory50.9M49.2M49.1M32.9M47.0M39.3M39.9M47.8M34.3M56.4M
Current assets149.4M140.0M194.8M268.3M190.6M217.9M242.3M195.0M273.3M233.9M
Property, plant and equipment230.0M215.1M229.2M244.4M259.9M274.8M
Total assets335.0M332.1M397.2M486.7M427.0M462.0M480.8M451.2M547.6M519.5M
Accounts payable13.8M9.32M13.6M12.8M12.1M16.5M16.1M9.55M11.2M9.77M
Current liabilities40.5M33.2M71.3M97.5M37.5M72.5M83.4M22.1M86.6M37.2M
Long-term debt95.3M104.7M114.1M158.0M170.0M170.0M180.0M180.0M180.0M170.5M
Total debt158.6M230.6M181.5M212.4M230.0M
Total liabilities135.9M138.2M185.6M255.6M208.2M244.0M263.4M202.1M266.6M207.8M
Shareholders' equity199.1M193.8M211.6M231.2M218.8M218.0M217.4M249.1M281.0M311.7M
Shares outstanding30.2M30.2M30.2M30.2M30.2M30.2M30.2M30.2M30.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations13.4M-10.2M13.2M43.5M12.3M7.57M-11.7M-2.60M-23.6M31.5M
Capital spending-5.38M-3.80M-585.0K-1.69M-7.89M-22.1M-1.48M-2.78M-4.82M-12.5M
Free cash flow7.98M-14.0M12.6M41.9M4.45M-14.5M-13.2M-5.42M-30.5M19.0M
Cash from investing32.1M-59.9M-646.0K-6.85M-5.97M-12.1M
Cash from financing-72.2M49.1M-30.8M-20.9M49.1M-60.0M60.0M2.86M
Dividends paid-7.14M
Share buybacks0
Change in cash-1.08M-56.9M-58.0M97.2M13.7M-73.2M36.8M-69.4M30.5M22.3M

Open Financials

Cap table

Built by 6ix from Visgeneer, Inc.’s releases

Common shares
30,181,000
Fully diluted
30,181,000

Fully diluted

LineShares
Common shares30,181,000

Share count over time

CountShares
Nov 22, 202630,181,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
台灣肥料股份有限公司3.15M10.4%Oct 31, 2026
戴鏗碩3.01M10.0%Oct 31, 2026
鉅立投資股份有限公司1.05M3.5%Oct 31, 2026
賀 玢585K1.9%Oct 31, 2026
張治平186K0.62%Oct 31, 2026
張本賢102K0.34%Oct 31, 2026
吳建成97,0000.32%Oct 31, 2026
吳建勳2,000<0.01%Oct 31, 2026
陳宥瑋2,000<0.01%Oct 31, 2026
陳雅貞00.00%Oct 31, 2026
All 15 holders
HolderSharesOf the companyAs of
李宗儒00.00%Oct 31, 2026
何上堂00.00%Oct 31, 2026
余尚武00.00%Oct 31, 2026
林伸全00.00%Oct 31, 2026
李金龍00.00%Oct 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ken-Shwo DaiChairman & CEO · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Visgeneer, Inc.